Is Setmelanotide (Imcivree) legal?
Setmelanotide (Imcivree) is an FDA approved drug. For drug-tested athletes it is not on the WADA prohibited list. Yes, pediatric endocrinology and metabolic-disease specialists prescribe for the genetic-obesity indications.. Legal status depends on your country and changes over time. This reflects US status at the time of writing and is not legal or medical advice.
Regulatory status
- FDA: Approved as Imcivree (2020) for obesity due to POMC, PCSK1, or LEPR deficiency. 2022 expansion: Bardet-Biedl syndrome.
- WADA: Not listed
- Prescription: Yes, pediatric endocrinology and metabolic-disease specialists prescribe for the genetic-obesity indications.
References
- Setmelanotide for Obesity due to LEPR or POMC deficiency — Clément K et al., Lancet Diabetes Endocrinol, 2020
- Efficacy and safety of setmelanotide in patients with Bardet-Biedl syndrome and Alström syndrome: a phase 3 trial — Haqq AM et al., The Lancet Diabetes & Endocrinology, 2022
- Imcivree (setmelanotide) — Drugs@FDA approval record (ApplNo 213793) — FDA, Drugs@FDA
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Setmelanotide (Imcivree)
Full Setmelanotide (Imcivree) breakdownSetmelanotide (Imcivree) what it's used forSetmelanotide (Imcivree) side effectsSetmelanotide (Imcivree) how to take itSetmelanotide (Imcivree) mistakes to avoidSetmelanotide (Imcivree) who should avoid itSetmelanotide (Imcivree) half-lifeSetmelanotide (Imcivree) how long to workSetmelanotide (Imcivree) how it worksAsk the AI Coach
Last updated 2026-06-15.